3 recruiting, 1 completed. 3 Not applicable, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 3 | Recruiting 2, Completed 1 |
| Phase 1 | 1 | Recruiting 1 |
Follow StrataMGT: new trials by email Literature Review of StrataMGT trials Research Report on StrataMGT
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| StrataMGT in the Reduction of Vulvar Lichen Sclerosus (LS) Symptoms StrataMGT, Placebo - Vulvar Lichen Sclerosus | Phase 1 | Recruiting | Andrew T. Goldstein, MD | 100 | 2024-10-16 | 2024-11-08 |
| StrataMGT for the Treatment of Vulvar Lichen Sclerosus StrataMGT - Vulvar Lichen Sclerosus | Not applicable | Completed | Center for Vulvovaginal Disorders | 5 | 2024-04-16 | 2025-02-07 |
| VALOR: Vaginal Atrophy & Long-term Observation of Recovery 7-0940 - Atrophic Vaginitis, Vaginal Atrophy | Not applicable | Recruiting | Stratpharma AG | 2000 | 2023-10-30 | 2026-02-20 |
| Silicone Gel vs. Estrogen Vaginal Cream for the Management of Genitourinary Syndrome of Menopause StrataMGT, Estrace 0.01% Vaginal Cream - Genitourinary Syndrome of Menopause | Not applicable | Recruiting | Stratpharma AG | 100 | 2023-04-04 | 2026-02-20 |
Vulvar Lichen Sclerosus (3) · Atrophic Vaginitis (1)
Stratpharma AG (2) · Andrew T. Goldstein, MD (1) · Center for Vulvovaginal Disorders (1)
United States (4)
Chailee Moss, MD (1) · Jill Krapf, MD (1)